e-Drug3D

1291

CASPOFUNGIN


INN
CASPOFUNGIN

cas 162808-62-0
CLASS

ANTIINFECTIVES
ECHINOCANDIN ANTIFUNGAL
INHIBITOR

ROUTE (list)

INTRAVENOUS

ATC code

J02AX04

PK parameters

VD 8.45 LITER (65 KILOGRAM)
Cl 0.72 LITER / HOUR
PPB 97 PERCENT
t1/2 27 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET BETA-1,3-GLUCAN SYNTHASE

DrugCentral

Beta-1,3-glucan synthase catalytic subunit 1 UNIPROT O13428 GSC1

1,3-beta-glucan synthase catalytic subunit FksP UNIPROT Q4WLT4

Download SDF file 1-[(4R,5S)-5-[(2-aminoethyl)amino] -N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R) -3-hydroxy-L-ornithine] pneumocandin B0

Formula:
C52H88N10O15

Calculated chemical properties:

MW 1093.32
NB_atoms 77
XLogP -3.31
PSA 360.057
NB_HD 18
NB_HA 25
fsp3 0.75
Lipinski(0=no;1=yes) 0

FDA
NDA 021227 (pdf not found) INN (CASPOFUNGIN ACETATE) CANCIDAS (MERCK) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 206110 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2016
NDA 207092 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (GLAND) APPROVAL= AP YEAR= 2017
NDA 207650 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 200833 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (HENGRUI PHARMA) APPROVAL= AP YEAR= 2018
NDA 205923 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (XELLIA PHARMS APS) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 209489 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (CIPLA) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 211263 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (AREVA PHARMS) APPROVAL= AP YEAR= 2021
NDA 216506 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (HANGZHOU ZHONGMEI) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL